PRF Technologies (PRFX) Shares Outstanding (Diluted Average) (2020 - 2025)
PRF Technologies (PRFX) recorded quarterly Shares Outstanding (Diluted Average) of $647973.0 in Q4 2025, down 40.55% on a QoQ basis from $1.1 million in Q2 2025, and up 368.68% year-over-year from $138254.0 in Q4 2024.
PRF Technologies (PRFX) Shares Outstanding (Diluted Average) (2020 - 2025) Analysis & Trends
PRF Technologies has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $647973.0 for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 368.68% year-over-year to $647973.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $647973.0 (up 368.68% YoY) and the FY2025 annual result came in at $647973.0, up 368.68% from the prior year.
- Shares Outstanding (Diluted Average) fell to $647973.0 in Q4 2025, from $1.1 million in the prior quarter.
- Over five years, Shares Outstanding (Diluted Average) peaked at $1.1 million in Q2 2025 and troughed at $160.0 in Q1 2022.
- A 5-year average of $186817.2 and a median of $4120.0 in 2023 frame the typical range for Shares Outstanding (Diluted Average).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Diluted Average) plunged 91.67% — and 2025, when it surged 1626.05%.
- Tracing PRFX's Shares Outstanding (Diluted Average) over 5 years: stood at $999562.0 in 2021, then slumped by 86.14% to $138548.0 in 2022, then tumbled by 45.14% to $76005.0 in 2023, then jumped by 81.9% to $138254.0 in 2024, then jumped by 368.68% to $647973.0 in 2025.
- Business Quant data shows PRFX's Shares Outstanding (Diluted Average) at $647973.0 in Q4 2025, $1.1 million in Q2 2025, and $138254.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 228.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | PRF Technologies | 933,081.16 | -2.46 Mn | - | 647,973.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 647,973.00 |
| Jun 30, 2025 | 1.09 Mn |
| Dec 31, 2024 | 138,254.00 |
| Jun 30, 2024 | 63,150.00 |
| Mar 31, 2024 | 2,720.00 |
| Dec 31, 2023 | 76,005.00 |
| Sep 30, 2023 | 3,640.00 |
| Jun 30, 2023 | 4,120.00 |
| Mar 31, 2023 | 2,120.00 |
| Dec 31, 2022 | 138,548.00 |
| Sep 30, 2022 | 5,200.00 |
| Jun 30, 2022 | 3,250.00 |
| Mar 31, 2022 | 160.00 |
| Dec 31, 2021 | 999,562.00 |
| Sep 30, 2021 | 570.00 |
| Jun 30, 2021 | 390.00 |
| Mar 31, 2021 | 230.00 |
| Dec 31, 2020 | 3.24 Mn |
| Sep 30, 2020 | 2,200.00 |
| Jun 30, 2020 | 4,440.00 |